Radiation pneumonitis in lung cancer patients treated with high dose radiotherapy - Role of concurrent medications

被引：0
|
作者：
Bezjak, A [1 ]
Soyfer, V [1 ]
Yi, QL [1 ]
Sun, A [1 ]
Kane, G [1 ]
Waldron, J [1 ]
Cho, J [1 ]
Wells, W [1 ]
Payne, D [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2005年 / 76卷
关键词：
D O I：
10.1016/S0167-8140(05)80231-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70
引用
收藏
页码：S21 / S22
页数：2
相关论文
共 50 条
  • [41] Associations Between Mean Lung Dose and Prevalence of Radiation Pneumonitis in Elderly Lung Cancer Patients
    Rades, Dirk
    Cremers, Florian
    Janssen, Stefan
    Bartscht, Tobias
    Kristiansen, Charlotte
    Timke, Carmen
    Duma, Marciana n.
    Yu, Nathan y.
    Bohnet, Sabine
    ANTICANCER RESEARCH, 2024, 44 (05) : 2073 - 2079
  • [42] Clinical predictors of severe radiation pneumonitis in patients undergoing thoracic radiotherapy for lung cancer
    Yan, Yujie
    Zhu, Yaoyao
    Yang, Shuangyan
    Qian, Cheng
    Zhang, Ying
    Yuan, Xiaoshuai
    Hu, Min
    Kang, Jingjing
    Jiang, Chenxue
    Hu, Minren
    Zhao, Ruifeng
    Zhao, Lan
    Xu, Yaping
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (05) : 1069 - 1083
  • [43] Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients
    Yin, Hanjing
    Jia, Wenxiao
    Yu, Jinming
    Zhu, Hui
    BMC CANCER, 2024, 24 (01)
  • [44] Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients
    Hanjing Yin
    Wenxiao Jia
    Jinming Yu
    Hui Zhu
    BMC Cancer, 24
  • [45] MEAN ESOPHAGEAL RADIATION DOSE IS PREDICTIVE FOR GRADE OF ACUTE ESOPHAGITIS IN LUNG CANCER PATIENTS TREATED WITH CONCURRENT 3D CONFORMAL RADIOTHERAPY AND CHEMOTHERAPY
    Ozgen, A.
    Hayran, M.
    Guney, Y.
    Kara, P.
    Kucukplakci, B.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S40 - S40
  • [46] Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation
    Zehentmayr, Franz
    Sprenger, Martin
    Rettenbacher, Lukas
    Wass, Romana
    Porsch, Peter
    Fastner, Gerd
    Pirich, Christian
    Studnicka, Michael
    Sedlmayer, Felix
    THORACIC CANCER, 2019, 10 (02) : 321 - 329
  • [47] Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy
    Meng, Yinnan
    Luo, Wei
    Wang, Wei
    Zhou, Chao
    Zhou, Suna
    Tang, Xingni
    Hou, Liqiao
    Kong, Feng-Ming Spring
    Yang, Haihua
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [48] ASSOCIATION OF P53 AND ATM POLYMORPHISMS WITH RISK OF RADIATION-INDUCED PNEUMONITIS IN LUNG CANCER PATIENTS TREATED WITH RADIOTHERAPY
    Yang, Ming
    Zhang, Li
    Bi, Nan
    Ji, Wei
    Tan, Wen
    Zhao, Lujun
    Yu, Dianke
    Wu, Chen
    Wang, Luhua
    Lin, Dongxin
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1402 - 1407
  • [49] Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy
    Isoyama, Shoko
    Yamaguchi, Kakuhiro
    Imano, Nobuki
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Miyamoto, Shintaro
    Nakashima, Taku
    Iwamoto, Hiroshi
    Fujitaka, Kazunori
    Hamada, Hironobu
    Nagata, Yasushi
    Hattori, Noboru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (11) : 1698 - 1705
  • [50] Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy
    Shoko Isoyama
    Kakuhiro Yamaguchi
    Nobuki Imano
    Shinjiro Sakamoto
    Yasushi Horimasu
    Takeshi Masuda
    Shintaro Miyamoto
    Taku Nakashima
    Hiroshi Iwamoto
    Kazunori Fujitaka
    Hironobu Hamada
    Yasushi Nagata
    Noboru Hattori
    International Journal of Clinical Oncology, 2022, 27 : 1698 - 1705
12345